Author
Dana-Farber Cancer InstituteORCID 0000-0001-7768-8956Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
4 papers
Recent·Most cited
Prathyusha Konda, Alexandra J. Wakolbinger, Yantong Cui…·Srinivas Raghavan Viswanathan
This study identifies fusion-driven oncogenic programs in translocation renal cell carcinoma (tRCC) that shape an immunosuppressive tumor microenvironment, explaining its reduced immunotherapy response.
Ananthan Sadagopan, Maximilian Carson, Eriks J. Zamurs…·William J. Gibson
This paper identifies a bifunctional small molecule that can induce both transactivation and repression of gene expression depending on cellular context.
Jiao Li, Kaimeng Huang, Meha Thakur…·Srinivas Raghavan Viswanathan
This study identifies TFE3 fusions driving OXPHOS in tRCC and reveals EGLN1 inhibition as a therapeutic target.
Ananthan Sadagopan, Bingchen Li, Jiao Li…·Srinivas Raghavan Viswanathan
This study uses machine learning to infer gene dependencies from tumor transcriptomes, identifying cancer vulnerabilities in rare cancers without experimental screening.